ATE10099T1 - 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. - Google Patents
3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.Info
- Publication number
- ATE10099T1 ATE10099T1 AT81850039T AT81850039T ATE10099T1 AT E10099 T1 ATE10099 T1 AT E10099T1 AT 81850039 T AT81850039 T AT 81850039T AT 81850039 T AT81850039 T AT 81850039T AT E10099 T1 ATE10099 T1 AT E10099T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- butyl
- ethyl
- compounds
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
| EP81850039A EP0038784B1 (de) | 1980-04-18 | 1981-03-09 | 3,8-Dialkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE10099T1 true ATE10099T1 (de) | 1984-11-15 |
Family
ID=20340763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT81850039T ATE10099T1 (de) | 1980-04-18 | 1981-03-09 | 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4546182A (de) |
| EP (1) | EP0038784B1 (de) |
| JP (1) | JPS56166191A (de) |
| AT (1) | ATE10099T1 (de) |
| AU (1) | AU543122B2 (de) |
| CA (1) | CA1156229A (de) |
| DD (1) | DD158400A5 (de) |
| DE (1) | DE3166893D1 (de) |
| DK (1) | DK151631B (de) |
| ES (1) | ES501400A0 (de) |
| FI (1) | FI69465C (de) |
| GR (1) | GR82347B (de) |
| HU (1) | HU185254B (de) |
| IE (1) | IE51106B1 (de) |
| NO (1) | NO811161L (de) |
| NZ (1) | NZ196829A (de) |
| PH (1) | PH16264A (de) |
| PL (1) | PL134762B1 (de) |
| PT (1) | PT72881B (de) |
| SE (1) | SE8002910L (de) |
| ZA (1) | ZA811729B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| US4710503A (en) * | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
| GB8618931D0 (en) * | 1986-08-02 | 1986-09-10 | Euro Celtique Sa | 6-thioxanthines |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| JP2843634B2 (ja) * | 1989-03-06 | 1999-01-06 | 協和醗酵工業株式会社 | キサンチン誘導体 |
| IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
| AU5436790A (en) * | 1989-04-19 | 1990-11-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Sulfer-containing xanthine derivatives as adenosin antagonists |
| CA2030112A1 (en) * | 1989-11-24 | 1991-05-25 | Yasuo Ito | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| US5366977A (en) * | 1992-09-29 | 1994-11-22 | The United States Of America, As Represented By The Department Of Health And Human Services | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
| DE4311538C1 (de) * | 1993-04-07 | 1994-10-06 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil |
| AU6781194A (en) * | 1993-05-03 | 1994-11-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| US6316423B1 (en) | 1996-04-10 | 2001-11-13 | The United States Of America As Represented By The Departmant Of Health And Human Services | Method of treating ischemic, hypoxic and anoxic brain damage |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53890B2 (de) * | 1972-04-22 | 1978-01-12 | ||
| US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
| CA1077932A (en) * | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
| SE416810C (sv) * | 1977-10-14 | 1982-05-11 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| SE7810946L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
-
1980
- 1980-04-18 SE SE8002910A patent/SE8002910L/xx not_active Application Discontinuation
-
1981
- 1981-03-09 AT AT81850039T patent/ATE10099T1/de not_active IP Right Cessation
- 1981-03-09 EP EP81850039A patent/EP0038784B1/de not_active Expired
- 1981-03-09 DE DE8181850039T patent/DE3166893D1/de not_active Expired
- 1981-03-16 ZA ZA00811729A patent/ZA811729B/xx unknown
- 1981-03-17 CA CA000373230A patent/CA1156229A/en not_active Expired
- 1981-04-01 PH PH25455A patent/PH16264A/en unknown
- 1981-04-03 NO NO811161A patent/NO811161L/no unknown
- 1981-04-08 IE IE769/81A patent/IE51106B1/en unknown
- 1981-04-14 DK DK168281AA patent/DK151631B/da active IP Right Grant
- 1981-04-14 DD DD81229229A patent/DD158400A5/de unknown
- 1981-04-15 NZ NZ196829A patent/NZ196829A/en unknown
- 1981-04-15 ES ES501400A patent/ES501400A0/es active Granted
- 1981-04-15 GR GR64702A patent/GR82347B/el unknown
- 1981-04-15 AU AU69555/81A patent/AU543122B2/en not_active Ceased
- 1981-04-16 PT PT72881A patent/PT72881B/pt unknown
- 1981-04-16 FI FI811212A patent/FI69465C/fi not_active IP Right Cessation
- 1981-04-17 HU HU811020A patent/HU185254B/hu unknown
- 1981-04-17 JP JP5724181A patent/JPS56166191A/ja active Pending
- 1981-04-17 PL PL1981230737A patent/PL134762B1/pl unknown
-
1983
- 1983-08-16 US US06/523,731 patent/US4546182A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU543122B2 (en) | 1985-04-04 |
| US4546182A (en) | 1985-10-08 |
| EP0038784A2 (de) | 1981-10-28 |
| ZA811729B (en) | 1982-04-28 |
| DE3166893D1 (en) | 1984-12-06 |
| FI69465B (fi) | 1985-10-31 |
| AU6955581A (en) | 1981-10-22 |
| PL134762B1 (en) | 1985-09-30 |
| DK168281A (da) | 1981-10-19 |
| PT72881B (en) | 1983-03-29 |
| CA1156229A (en) | 1983-11-01 |
| EP0038784B1 (de) | 1984-10-31 |
| IE810796L (en) | 1981-10-18 |
| HU185254B (en) | 1984-12-28 |
| NO811161L (no) | 1981-10-19 |
| ES8203088A1 (es) | 1982-02-16 |
| GR82347B (de) | 1984-12-13 |
| SE8002910L (sv) | 1981-10-19 |
| DK151631B (da) | 1987-12-21 |
| FI69465C (fi) | 1986-02-10 |
| IE51106B1 (en) | 1986-10-01 |
| NZ196829A (en) | 1984-12-14 |
| PT72881A (en) | 1981-05-01 |
| JPS56166191A (en) | 1981-12-21 |
| EP0038784A3 (en) | 1982-01-20 |
| FI811212L (fi) | 1981-10-19 |
| PL230737A1 (de) | 1982-03-29 |
| DD158400A5 (de) | 1983-01-12 |
| ES501400A0 (es) | 1982-02-16 |
| PH16264A (en) | 1983-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES485188A1 (es) | Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas | |
| ES8604565A1 (es) | Un derivado de acido 6-fluor-1, 4-dihidro-4-oxo-7-piperazinil-quinolin sustituido-3-carboxilico | |
| ATE10099T1 (de) | 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. | |
| DE3363550D1 (en) | New nitro aliphatic compounds, process for preparation thereof and use thereof | |
| EP0138344A3 (de) | Pyridazinonen als beta-adrenergetische Antagonisten | |
| DE3277971D1 (en) | Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use | |
| ES8308833A1 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
| ES8307737A1 (es) | "un procedimiento para la preparacion de mercapto-acil-carnitinas". | |
| ES8307778A1 (es) | Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos. | |
| FR2421891A1 (fr) | Obtention industrielle d'amides de la pyrrolidine ethyl amine | |
| JPS5239622A (en) | Process for preparation of methacrylic acid | |
| DE3262166D1 (en) | A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition | |
| KR890009919A (ko) | 4- 헤테로아릴-1,3- 벤조디아제핀 및 2-치환된-α-(헤테로아릴) 벤젠에탄아민, 이의 제조방법 및 약제로서의 이의 용도 | |
| JPS5780321A (en) | Cardiotonic agent | |
| IL85229A0 (en) | Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof | |
| ES8502128A1 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
| JPS525782A (en) | Preparation of 1-phthalazinone | |
| DE3065093D1 (en) | Therapeutic composition based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation | |
| KR830005222A (ko) | 만성 폐쇄성 기도 질병 및 심장혈관 질병치료용의 3,8-디알릴크산틴의 제조방법 및 그 조성물과 치료방법 | |
| DE3482857D1 (de) | 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die bekaempfung von herz- und gefaesskrankheiten. | |
| ATE24715T1 (de) | Cycloaliphatische aminosulfonsaeurederivate, verfahren zu deren herstellung und arzneimittel zur bekaempfung von herz- und gefaesskrankheiten. | |
| JPS56169656A (en) | Bis(substituted phenoxyacetic acid)-n- alkyldialkanolamine, its manufacture and brain trouble treating agent containing it as major component | |
| JPS53132597A (en) | Cytidylic acid derivative and its preparation | |
| JPS5242849A (en) | Process for preparation of 2-alkylcyclopentadienylethanol | |
| JPS5278821A (en) | Isolation of adipic acid from composition containing glutaric acid, su ccinic acid and adipic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |